ກົມອາຫານ ແລະ ຢາ :: ກະຊວງສາທາລະນະສຸກ, ສປປລາວ ::

Items	Registration information
ID	949
No	949
Brand Name	PHOLENVA 4
Ingredients	LENVATINIB 4 MG
Dosage Form	CAPSULE
Primary Packaging	BLISTERPACK
Storage	STORE IN DRY PLACE , AT TEMPERATURE 15-30 C, PROTECT FROM LIGHT
Shelf Life	3 YEARS
Pack Size	BOX OF 3 X 10'S
Dispensing Category	Prescription only
ATC Classification
Pharmaceutical Class	ANTINEOPLASTIC
Indications	FOR THE TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE REFRACTORY DIFFERENTIATED THYROID CANCER
Contraindications	NONE
Side Effects	HYPERTENSION, CARDIAC DYSFUNCTION, HEPATOTOXICITY, PROTEINUREA, DIARREA, HYPOCALCEMIA, HEMORRHAGIC EVENT
Unit Price
EDL	No
Description	WHITE-YELLOW CAPSULE CONTAINING WHITE GRANULES
Note
License Owner	FACTORY NO.2
Manufacturer	FACTORY NO. 2
Country	LAO PDR
Import Registration No	02 L 0823/20
Import Registration Date	2020-02-01
Activity	CERTIFICATE RELEASED
Applied Date
FDD Registration No	02 L 0823/20
FDD Registration Date	2023-08-29
Expiry Date	2026-08-28